Whellan DJ - Search Results

1

Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure (from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing).

Bensimhon DR, Leifer ES, Ellis SJ, Fleg JL, Keteyian SJ, Piña IL, Kitzman DW, McKelvie RS, Kraus WE, Forman DE, Kao AJ, Whellan DJ, O'Connor CM, Russell SD; HF-ACTION Trial Investigators. Bensimhon DR, et al. Among authors: whellan dj. Am J Cardiol. 2008 Sep 15;102(6):712-7. doi: 10.1016/j.amjcard.2008.04.047. Epub 2008 Jul 9. Am J Cardiol. 2008. PMID: 18773994 Free PMC article. Clinical Trial.

2

Disease management of congestive heart failure.

Whellan DJ, Gattis WA, Gaulden L, Granger B, O'Connor CM. Whellan DJ, et al. Am J Manag Care. 1999 Apr;5(4):499-507; quiz 508-9. Am J Manag Care. 1999. PMID: 10387388 Free article.

3

Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study.

Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Gattis WA, et al. Among authors: whellan dj. Arch Intern Med. 1999 Sep 13;159(16):1939-45. doi: 10.1001/archinte.159.16.1939. Arch Intern Med. 1999. PMID: 10493325 Clinical Trial.

4

Cardiac rehabilitation and survival in patients with left ventricular systolic dysfunction.

Whellan DJ, Shaw LK, Bart BA, Kraus WE, Califf RM, O'Connor CM. Whellan DJ, et al. Am Heart J. 2001 Jul;142(1):160-6. doi: 10.1067/mhj.2001.115785. Am Heart J. 2001. PMID: 11431673

5

The benefit of implementing a heart failure disease management program.

Whellan DJ, Gaulden L, Gattis WA, Granger B, Russell SD, Blazing MA, Cuffe MS, O'Connor CM. Whellan DJ, et al. Arch Intern Med. 2001 Oct 8;161(18):2223-8. doi: 10.1001/archinte.161.18.2223. Arch Intern Med. 2001. PMID: 11575979

6

The state of exercise training: a need for action.

Whellan DJ, O'Connor CM. Whellan DJ, et al. Am Heart J. 2002 Jul;144(1):1-4. doi: 10.1067/mhj.2002.123311. Am Heart J. 2002. PMID: 12094180 No abstract available.

7

Radionuclide viability testing: should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease?

Bourque JM, Velazquez EJ, Borges-Neto S, Shaw LK, Whellan DJ, O'Connor CM. Bourque JM, et al. Among authors: whellan dj. Am Heart J. 2003 May;145(5):758-67. doi: 10.1016/S0002-8703(02)94818-0. Am Heart J. 2003. PMID: 12766731 Review.

8

Depression and cardiovascular disease: mechanisms of interaction.

Joynt KE, Whellan DJ, O'Connor CM. Joynt KE, et al. Among authors: whellan dj. Biol Psychiatry. 2003 Aug 1;54(3):248-61. doi: 10.1016/s0006-3223(03)00568-7. Biol Psychiatry. 2003. PMID: 12893101 Review.

9

Training trials in heart failure: time to exercise restraint?

Whellan DJ, O'Connor CM, Pina I. Whellan DJ, et al. Am Heart J. 2004 Feb;147(2):190-2. doi: 10.1016/j.ahj.2003.09.008. Am Heart J. 2004. PMID: 14760309 No abstract available.

10

Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure.

Joynt KE, Gattis WA, Hasselblad V, Fuzaylov SY, Serebruany VL, Gurbel PA, Gaulden LH, Felker GM, Whellan DJ, O'Connor CM. Joynt KE, et al. Among authors: whellan dj. Am J Cardiol. 2004 Mar 15;93(6):783-5. doi: 10.1016/j.amjcard.2003.12.010. Am J Cardiol. 2004. PMID: 15019895

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

265 results

Search Page

Filters